Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Examining the Usefulness of the Charlson Comorbidity Index to Predict Early Mortality in Patients with Acute Myeloid Leukaemia

Mohamed Bakri Mohamed, Seán R Millar, Vitaliy Mykytiv, Rose McMorrow, Conan Donnelly, Paul M Walsh, Eamonn O'Leary, Nina Orfali, Philip Murphy, Paul V. Browne, John Quinn, Peter O'Gorman, Ruth Clifford, Ezzat El Hassadi, Oonagh Gilligan, Janusz Krawczyk, Michael E. O'Dwyer, Eva Szegezdi, Mary R Cahill

Blood (2021) 138 (Supplement 1): 1218.

https://doi.org/10.1182/blood-2021-149832

Published: 2021

Journal Articles

Highly Comprehensive Genomic Testing for CLL: WGS, One Key to CLL Patient Stratification

Blood (2018) 132 (Supplement 1): 3115.

https://doi.org/10.1182/blood-2018-99-115935

Published: 2018

Journal Articles

Detection of Clinically Relevant Molecular Alterations in Chronic Lymphocytic Leukemia (CLL) By Nanopore Sequencing

Adam Burns, BSc, PhD, David Robert Bruce, MRCP, Pauline Robbe, MSc, PhD, Adele Timbs, Basile Stamatopoulos, PhD, Ruth Clifford, FRCPath, PhD, Maria Lopopolo, Duncan Parkes, Kate E Ridout, PhD, Anna Schuh, MD PhD

Blood (2018) 132 (Supplement 1): 1847.

https://doi.org/10.1182/blood-2018-99-110948

Published: 2018

Journal Articles

The Contribution of Gene Mutations to Long-Term Clinical Outcomes: Data from the Randomised UK LRF CLL4 Trial

Blood (2017) 130 (Supplement 1): 259.

https://doi.org/10.1182/blood.V130.Suppl_1.259.259

Published: 2017

Journal Articles

Clinical Importance of DNA Methylation Signatures in Chronic Lymphocytic Leukaemia Patients Treated with Chemo-Immunotherapy

Blood (2017) 130 (Supplement 1): 56.

https://doi.org/10.1182/blood.V130.Suppl_1.56.56

Published: 2017

Journal Articles

Identifying High-Risk CLL to Predict Early Relapse after FCR Based Treatment Using Whole Genome Sequencing: First Results from the Genomics England CLL Pilot

Pauline Robbe, Kate Ridout, Jennifer Becq, Miao He, Ruth Clifford, MD, Reem Alsolami, Adam Burns, Samantha JL Knight, Melanie Oates, Dena Howard, Andrew R. Pettitt, Augusto Rendon, Niko Popitsch, Peter Hillmen, Jenny C Taylor, Mark Caulfield, David Bentley, Clare Turnbull, Anna Schuh, MD PhD

Blood (2016) 128 (22): 2022.

https://doi.org/10.1182/blood.V128.22.2022.2022

Published: 2016

Journal Articles

Characterization of Recurrent Mutations in Patient with a Richter Syndrome By Targeted Next Generation Sequencing

Basile Stamatopoulos, PhD, Pavlos Antoniou, Dimitris Vavoulis, Toby A. Eyre, MD, Ruth Clifford, MD, Maité Cabes, Msc, Hélène Dreau, MSc, Anna Schuh, MD PhD

Blood (2016) 128 (22): 3200.

https://doi.org/10.1182/blood.V128.22.3200.3200

Published: 2016

Journal Articles

Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations

Blood (2016) 127 (8): 1007–1016.

https://doi.org/10.1182/blood-2015-10-674572

Published: 2016

Includes: Supplemental data

Journal Articles

Genomic Disruption of the Histone Methyltransferase SETD2 in Chronic Lymphocytic Leukemia

Blood (2015) 126 (23): 365.

https://doi.org/10.1182/blood.V126.23.365.365

Published: 2015

Journal Articles

EGR2 Mutations in Chronic Lymphocytic Leukemia: A New Bad Player

Blood (2015) 126 (23): 4126.

https://doi.org/10.1182/blood.V126.23.4126.4126

Published: 2015

Journal Articles

Next-Generation Deep Sequencing Reveals Multiple Ighv Clones in One Third of CLL Patients Defining New Prognostic Subgroups and Improving Previous Classification

Basile Stamatopoulos, PhD, Adele Timbs, Msc, Hélène Dreau, MSc, Ruth Clifford, Pauline Robbe, MSc, Adam Burns, BSc, Joanne Mason, PhD, Anna Schuh, MD PhD

Blood (2015) 126 (23): 4127.

https://doi.org/10.1182/blood.V126.23.4127.4127

Published: 2015

Journal Articles

Presence of multiple recurrent mutations confers poor trial outcome of relapsed/refractory CLL

Blood (2015) 126 (18): 2110–2117.

https://doi.org/10.1182/blood-2015-05-647578

Published: 2015

Includes: Supplemental data

Journal Articles

The Identification of Further Minimal Regions of Overlap in Chronic Lymphocytic Leukemia Using High-Resolution SNP Arrays

Samantha JL Knight, PhD CBiol, MSB, FRCPath, Ruth Clifford, MD, Pauline Robbe, MSc, Sara DC Ramos, MSc, Adam Burns, BSc, Adele T Timbs, MSc, Reem Alsolami, BSc, Susanne Weller, PhD, Angela Hamblin, MDPhD, Joanne Mason, PhD, Melanie Oates, PhD, Michalis Titsias, PhD, Christopher Yau, DPhil, Chris C Holmes, PhD, Andrew R Pettitt, FRCP, PhD, Peter Hillmen, MB, ChB, PhD, Jenny Taylor, DPhil, Anna Shuh, MD PhD FRCP, FRCPath

Blood (2014) 124 (21): 3315.

https://doi.org/10.1182/blood.V124.21.3315.3315

Published: 2014

Journal Articles

Development and Evaluation of the Clinical Utility of a Next Generation Sequencing (NGS) Tool for Myeloid Disorders

Angela Hamblin, MDPhD, Adam Burns, BSc, Christopher Tham, BA, Ruth Clifford, MD, Pauline Robbe, MSc, Adele Timbs, MSc, Joanne Mason, PhD, Helene Dreau, MSc, Andreas Weller, PhD, Puthen Jithesh, PhD, Olivia Fox, BSc, Melody Tabiner, MA, Adam Mead, MDPhD, Andrew Peniket, MD, Paresh Vyas, MDPhD, Shirley Henderson, PhD, Anna Schuh, MDPhD

Blood (2014) 124 (21): 2373.

https://doi.org/10.1182/blood.V124.21.2373.2373

Published: 2014

Journal Articles

SAMHD1 is mutated recurrently in chronic lymphocytic leukemia and is involved in response to DNA damage

Blood (2014) 123 (7): 1021–1031.

https://doi.org/10.1182/blood-2013-04-490847

Published: 2014

Includes: Supplemental data

Journal Articles

Impact of isolated germline JAK2V617I mutation on human hematopoiesis

Adam J. Mead, Onima Chowdhury, Christian Pecquet, Alexandra Dusa, Petter Woll, Deborah Atkinson, Adam Burns, Joannah Score, Michelle Rugless, Ruth Clifford, Simon Moule, Nicola Bienz, Paresh Vyas, Nick Cross, Rosemary E. Gale, Shirley Henderson, Stefan N. Constantinescu, Anna Schuh, Sten Eirik W. Jacobsen

Blood (2013) 121 (20): 4156–4165.

https://doi.org/10.1182/blood-2012-05-430926

Published: 2013

Includes: Supplemental data

Journal Articles

SAMHD1, A Putative Tumour Suppressor, Is Recurrently Mutated in Chronic Lymphocytic Leukaemia, and Is Associated with Poor Risk Features

Ruth Clifford, Sam Ackroyd, Adam Burns, Adele Timbs, Jonathan Maelfait, Helene Dreau, Shirley Henderson, Mark Ross, David Bentley, Peter Hillmen, MBChB, PhD, Samantha Knight, Jenny Taylor, Chris S.R Hatton, Jan Rehwinkel, Yanick Crow, Anna Schuh

Blood (2012) 120 (21): 713.

https://doi.org/10.1182/blood.V120.21.713.713

Published: 2012

Journal Articles

Targeted Gene Profiling Identifies Differential Genetic Make-up Depending On Chronic Lymphocytic Leukaemia Subtype

Adam Burns, Ruth Clifford, MB, MRCP, Helene Dreau, MSc, Chris S.R Hatton, Shirley Henderson, PhD, Jenny Taylor, Anna Schuh, PhD

Blood (2012) 120 (21): 1383.

https://doi.org/10.1182/blood.V120.21.1383.1383

Published: 2012

Journal Articles

Monitoring chronic lymphocytic leukemia progression by whole genome sequencing reveals heterogeneous clonal evolution patterns

Anna Schuh, Jennifer Becq, Sean Humphray, Adrian Alexa, Adam Burns, Ruth Clifford, Stephan M. Feller, Russell Grocock, Shirley Henderson, Irina Khrebtukova, Zoya Kingsbury, Shujun Luo, David McBride, Lisa Murray, Toshi Menju, Adele Timbs, Mark Ross, Jenny Taylor, David Bentley

Blood (2012) 120 (20): 4191–4196.

https://doi.org/10.1182/blood-2012-05-433540

Published: 2012

Includes: Supplemental data

Journal Articles

Germline Activating JAK2 V617I Mutation in a Family with Hereditary Thrombocytosis

Adam J. Mead, M.D., Ph.D., Michelle Rugless, Petter Woll, Ph.D., Ruth Clifford, MB, MRCP, Debbie Atkinson, Simon Moule, Nicola Bienz, James S. Wainscoat, Paresh Vyas, Shirley Henderson, PhD, Sten Eirik W Jacobsen, M.D., Ph.D., Anna Schuh, PhD

Blood (2011) 118 (21): 1738.

https://doi.org/10.1182/blood.V118.21.1738.1738

Published: 2011

NARROW

Examining the Usefulness of the Charlson Comorbidity Index to Predict Early Mortality in Patients with Acute Myeloid Leukaemia

Highly Comprehensive Genomic Testing for CLL: WGS, One Key to CLL Patient Stratification

Detection of Clinically Relevant Molecular Alterations in Chronic Lymphocytic Leukemia (CLL) By Nanopore Sequencing

The Contribution of Gene Mutations to Long-Term Clinical Outcomes: Data from the Randomised UK LRF CLL4 Trial

Clinical Importance of DNA Methylation Signatures in Chronic Lymphocytic Leukaemia Patients Treated with Chemo-Immunotherapy

Identifying High-Risk CLL to Predict Early Relapse after FCR Based Treatment Using Whole Genome Sequencing: First Results from the Genomics England CLL Pilot

Characterization of Recurrent Mutations in Patient with a Richter Syndrome By Targeted Next Generation Sequencing

Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations

Genomic Disruption of the Histone Methyltransferase SETD2 in Chronic Lymphocytic Leukemia

EGR2 Mutations in Chronic Lymphocytic Leukemia: A New Bad Player

Next-Generation Deep Sequencing Reveals Multiple Ighv Clones in One Third of CLL Patients Defining New Prognostic Subgroups and Improving Previous Classification

Presence of multiple recurrent mutations confers poor trial outcome of relapsed/refractory CLL

The Identification of Further Minimal Regions of Overlap in Chronic Lymphocytic Leukemia Using High-Resolution SNP Arrays

Development and Evaluation of the Clinical Utility of a Next Generation Sequencing (NGS) Tool for Myeloid Disorders

SAMHD1 is mutated recurrently in chronic lymphocytic leukemia and is involved in response to DNA damage

Impact of isolated germline JAK2V617I mutation on human hematopoiesis

SAMHD1, A Putative Tumour Suppressor, Is Recurrently Mutated in Chronic Lymphocytic Leukaemia, and Is Associated with Poor Risk Features

Targeted Gene Profiling Identifies Differential Genetic Make-up Depending On Chronic Lymphocytic Leukaemia Subtype

Monitoring chronic lymphocytic leukemia progression by whole genome sequencing reveals heterogeneous clonal evolution patterns

Germline Activating JAK2 V617I Mutation in a Family with Hereditary Thrombocytosis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only